http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101982951-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 |
filingDate | 2015-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101982951-B1 |
titleOfInvention | New type of cytidine derivative and application thereof |
abstract | New types of cytidine derivatives having the general formula I and their uses are disclosed. The cytidine derivatives of the novel type of the present invention have a growth inhibitory effect as confirmed by tests on the colon carcinoma HCT-116 tumors possessed by nude mice; The antineoplastic activity of the compounds of the present invention is high, while the low toxicity of the compounds is evidenced by mortality data as well as the effect on body weight of colon cancer HCT-116 tumor-bearing mice. (I) |
priorityDate | 2014-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.